NCT07502950

Brief Summary

This prospective multicenter observational study aims to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings in clinically relevant settings. ROTEM is widely used to guide hemostatic therapy in perioperative and critically ill patients, but its interpretation is complex and subject to interobserver variability. The primary objective is to determine whether AI-based interpretation achieves agreement comparable to variability between expert clinicians. Secondary objectives include comparison of interpretation time, assessment of consistency of AI outputs, and evaluation of potential differences in clinical decision-making. ROTEM datasets will be independently assessed by multiple expert anesthesiologists and by an AI-based model using standardized input. Agreement between methods and variability of interpretation will be analyzed. The study aims to determine whether AI-assisted interpretation could serve as a reliable decision-support tool and reduce variability in ROTEM-guided clinical practice.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Sep 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 31, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

9 months

First QC Date

March 25, 2026

Last Update Submit

March 25, 2026

Conditions

Keywords

ROTEMthromboelastographycoagulopathy

Outcome Measures

Primary Outcomes (1)

  • Agreement between AI-based and expert interpretation of ROTEM findings

    Agreement between artificial intelligence (AI)-based interpretation and expert interpretation of ROTEM findings will be assessed and compared to inter-expert agreement. Agreement will be evaluated for predefined clinical decision outputs, including: * presence of coagulation disorder (yes/no), * identification of dominant coagulation abnormality (categorical), * selection of therapeutic intervention (categorical), * and recommended treatment dose (continuous). Agreement will be quantified using appropriate statistical methods for categorical and continuous data (e.g., Cohen's/Fleiss' kappa and intraclass correlation coefficients).

    Up to 24 hours after ROTEM measurement (time required for interpretation and data recording).

Secondary Outcomes (4)

  • Interpretation time

    Up to 24 hours after ROTEM measurement.

  • Consistency of interpretation (intra-method variability)

    Up to 24 hours after ROTEM measurement

  • Proportion of clinically discordant decisions

    Up to 24 hours after ROTEM measurement

  • Inter-expert agreement

    Up to 24 hours after ROTEM measurement

Other Outcomes (1)

  • Potential treatment change

    Up to 24 hours after ROTEM measurement

Study Arms (1)

Patients indicated for thromboelastography.

Intensive care unit adult patients that are indicated for thromboelastography.

Other: Large Language Model (LLM) artificial intelligence assesment

Interventions

The thromboelastography record will be assessed by LLM based artificial intelligence.

Patients indicated for thromboelastography.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adult patients undergoing rotational thromboelastometry (ROTEM) as part of routine clinical care in participating centers. Patients will be recruited from perioperative and intensive care settings, including major surgery, trauma, and critical illness, where assessment of coagulation status is clinically indicated. This study reflects real-world practice, with no modification of standard care. The unit of analysis will be individual ROTEM measurements rather than individual patients, as repeated measurements may occur during clinical management. Only ROTEM datasets with complete graphical and numerical outputs and meeting predefined quality criteria will be included.

You may qualify if:

  • Adult patients (age ≥18 years)
  • ROTEM analysis performed using a ROTEM Sigma device as part of routine clinical care
  • Availability of complete ROTEM output (graphical and numerical data)
  • ROTEM measurement obtained in a clinical context where assessment of coagulation status is indicated (e.g., perioperative setting, trauma, or critical illness)

You may not qualify if:

  • ROTEM measurements performed using the HEPTEM channel
  • Incomplete or missing ROTEM data preventing standardized evaluation
  • ROTEM measurements obtained under non-standardized or technically unreliable conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hemostatic Disorders

Interventions

Large Language Models

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Deep LearningMachine LearningArtificial IntelligenceAlgorithmsMathematical ConceptsNeural Networks, Computer

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
deputy for science and research

Study Record Dates

First Submitted

March 25, 2026

First Posted

March 31, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

March 31, 2026

Record last verified: 2026-03